Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 175,800.00 KRW | +0.06% |
|
+0.34% | +1.98% |
| Jul. 14 | Celltrion Terminates, Withdraws EMA Trial Application for CT-P51 Biosimilar | MT |
| Jul. 07 | Celltrion Submits Amendment for Phase 3 Trial of Cancer Biosimilar to US FDA | MT |
| Market Cap | 40,316B 27.11B 23.69B 21.86B 20.15B 37.98B 2,611B 38.83B 261B 103B 1,279B 102B 99.59B 4,402B | P/E 2026 * |
27.1x | P/E 2027 * | 24.1x |
|---|---|---|---|---|---|
| Enterprise Value | 42.36B 28.48M 24.89M 22.97M 21.17M 39.91M 2.74B 40.79M 275M 108M 1.34B 107M 105M 4.62B | EV / Sales 2026 * |
7.96x | EV / Sales 2027 * | 6.75x |
| Free-Float |
57.91% | Yield 2026 * |
0.42% | Yield 2027 * | 0.45% |
| 1 day | +0.06% | ||
| 1 week | +0.34% | ||
| Current month | +1.44% | ||
| 1 month | +3.23% | ||
| 3 months | -11.04% | ||
| 6 months | -10.61% | ||
| Current year | +1.98% |
| 1 week | 171,200 |  | 179,300 |
| 1 month | 159,200 | | 188,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 2015-03-19 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 2021-03-25 |
Hyeok-Jae Lee
PSD | President | 50 | 2026-02-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 2005-03-31 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 1,000 | 0.0004% | |||
| 1/16/26 | Sell | 500 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.06% | +0.34% | +2.38% | +34.47% | 27.11B | |
| -1.29% | -3.11% | -0.35% | +2.64% | 49.18B | |
| +3.90% | -0.39% | +386.06% | +588.97% | 39.58B | |
| -1.70% | +4.46% | +5.93% | +61.54% | 34.69B | |
| -2.01% | -0.76% | +28.41% | -8.52% | 34.42B | |
| +0.46% | -3.49% | - | - | 16.21B | |
| -0.04% | -0.09% | +72.42% | +116.45% | 15.36B | |
| +1.12% | +1.91% | +14.54% | +15.44% | 14.05B | |
| 0.00% | +1.36% | +18.43% | -31.23% | 13.02B | |
| -0.08% | -3.01% | +1,282.83% | +619.81% | 11.76B | |
| Average | +0.04% | -0.28% | +201.18% | +155.51% | 25.54B | |
| Weighted average by Cap. | -0.05% | -0.31% | +138.60% | +146.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,321B 3.58B 3.13B 2.89B 2.66B 5.01B 345B 5.12B 34.49B 13.57B 169B 13.44B 13.14B 581B | 6,181B 4.16B 3.63B 3.35B 3.09B 5.82B 400B 5.95B 40.06B 15.76B 196B 15.61B 15.27B 675B |
| Net income | 1,484B 998M 872M 805M 742M 1.4B 96.08B 1.43B 9.62B 3.78B 47.06B 3.75B 3.66B 162B | 1,698B 1.14B 998M 921M 849M 1.6B 110B 1.64B 11.01B 4.33B 53.86B 4.29B 4.19B 185B |
| Net Debt | 2,041B 1.37B 1.2B 1.11B 1.02B 1.92B 132B 1.97B 13.23B 5.2B 64.75B 5.16B 5.04B 223B | 1,427B 960M 839M 774M 714M 1.34B 92.45B 1.37B 9.25B 3.64B 45.28B 3.61B 3.53B 156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-16 | ₩175,800.00 | +0.06% | 498,638 |
| 26-07-15 | ₩175,700.00 | +1.68% | 491,182 |
| 26-07-14 | ₩172,800.00 | -1.31% | 710,511 |
| 26-07-13 | ₩175,100.00 | -0.06% | 646,548 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
